Anticancer Agent “TASFYGO Tablets 35mg” (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Most cancers with FGFR2 Gene Fusion or Rearrangements By Investing.com

Breakthrough Remedy designation for Sanbexin sublingual tablets granted by america Meals and Drug Administration By Investing.com

Progressive Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Authorised for Advertising and marketing in China – Blockchain Information Website